Involvement of ATM-mediated Chk1/2 and JNK kinase signaling activation in HKH40A-induced cell growth inhibition

Ziqiu Wang, Meifang Wang, Sid Kar, Brian I. Carr

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

HKH40A (RTA 502), or 5-nitro-2-(3-{4-[3-(8-methoxy-6-oxo-6H-2,10b-diaza- aceanthrylen-5-ylamino)propyl]piperazin-1-yl}-propyl)-2-aza-phenalene-1,3-dione, has been shown to be a potent cell growth inhibitor. To investigate HKH40A actions, we focused on exploring the signal transduction pathways that are involved in its cell growth inhibitory mechanisms. We found that HKH40A activated ataxia telangiectasia mutated (ATM) kinase, which then triggered activation of the Chk1/2 signaling pathway, evidenced by Chk1/2 mediated inhibitory phosphorylation of Cdc25C protein phosphatase. This resulted in Cdk1 tyrosine phosphorylation at Tyr-15, leading to cell cycle block at G2/M phase. HKH40A also activated the c-Jun N-terminal kinase (JNK) pathway, most likely regulated by ATM kinase, since pre-treatment of Hep3B cells with ATM inhibitor KU-55933 or ATM siRNA transfection antagonized HKH40A-induced c-Jun phosphorylation. HKH40A-induced apoptosis was probably mediated by JNK-H2A.X interaction, since phospho-c-Jun and phospho-H2A.X were able to co-localize in the nucleus and to co-immuno-precipitate. Furthermore, inhibition of JNK kinase activity by JNK inhibitor SP600125 abolished both HKH40A-induced H2A.X phosphorylation and apoptosis. Our data support the hypothesis that binding of HKH40Ato cellular DNA likely activates ATM kinase, which then induces parallel Chk 1/2 and JNK signaling pathways, leading to G2/M cell cycle block and apoptosis.

Original languageEnglish
Pages (from-to)213-220
Number of pages8
JournalJournal of Cellular Physiology
Volume221
Issue number1
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Ataxia Telangiectasia
Cell growth
Phosphotransferases
Chemical activation
Phosphorylation
Growth
Apoptosis
Cell Cycle
cdc25 Phosphatases
Cells
Growth Inhibitors
Signal transduction
RTA 502
JNK Mitogen-Activated Protein Kinases
G2 Phase
Phosphoprotein Phosphatases
Cell Division
Small Interfering RNA
Transfection
Tyrosine

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Physiology

Cite this

Involvement of ATM-mediated Chk1/2 and JNK kinase signaling activation in HKH40A-induced cell growth inhibition. / Wang, Ziqiu; Wang, Meifang; Kar, Sid; Carr, Brian I.

In: Journal of Cellular Physiology, Vol. 221, No. 1, 10.2009, p. 213-220.

Research output: Contribution to journalArticle

Wang, Ziqiu ; Wang, Meifang ; Kar, Sid ; Carr, Brian I. / Involvement of ATM-mediated Chk1/2 and JNK kinase signaling activation in HKH40A-induced cell growth inhibition. In: Journal of Cellular Physiology. 2009 ; Vol. 221, No. 1. pp. 213-220.
@article{46e3df7b5b704052838089d0e441e8aa,
title = "Involvement of ATM-mediated Chk1/2 and JNK kinase signaling activation in HKH40A-induced cell growth inhibition",
abstract = "HKH40A (RTA 502), or 5-nitro-2-(3-{4-[3-(8-methoxy-6-oxo-6H-2,10b-diaza- aceanthrylen-5-ylamino)propyl]piperazin-1-yl}-propyl)-2-aza-phenalene-1,3-dione, has been shown to be a potent cell growth inhibitor. To investigate HKH40A actions, we focused on exploring the signal transduction pathways that are involved in its cell growth inhibitory mechanisms. We found that HKH40A activated ataxia telangiectasia mutated (ATM) kinase, which then triggered activation of the Chk1/2 signaling pathway, evidenced by Chk1/2 mediated inhibitory phosphorylation of Cdc25C protein phosphatase. This resulted in Cdk1 tyrosine phosphorylation at Tyr-15, leading to cell cycle block at G2/M phase. HKH40A also activated the c-Jun N-terminal kinase (JNK) pathway, most likely regulated by ATM kinase, since pre-treatment of Hep3B cells with ATM inhibitor KU-55933 or ATM siRNA transfection antagonized HKH40A-induced c-Jun phosphorylation. HKH40A-induced apoptosis was probably mediated by JNK-H2A.X interaction, since phospho-c-Jun and phospho-H2A.X were able to co-localize in the nucleus and to co-immuno-precipitate. Furthermore, inhibition of JNK kinase activity by JNK inhibitor SP600125 abolished both HKH40A-induced H2A.X phosphorylation and apoptosis. Our data support the hypothesis that binding of HKH40Ato cellular DNA likely activates ATM kinase, which then induces parallel Chk 1/2 and JNK signaling pathways, leading to G2/M cell cycle block and apoptosis.",
author = "Ziqiu Wang and Meifang Wang and Sid Kar and Carr, {Brian I.}",
year = "2009",
month = "10",
doi = "10.1002/jcp.21844",
language = "English",
volume = "221",
pages = "213--220",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Involvement of ATM-mediated Chk1/2 and JNK kinase signaling activation in HKH40A-induced cell growth inhibition

AU - Wang, Ziqiu

AU - Wang, Meifang

AU - Kar, Sid

AU - Carr, Brian I.

PY - 2009/10

Y1 - 2009/10

N2 - HKH40A (RTA 502), or 5-nitro-2-(3-{4-[3-(8-methoxy-6-oxo-6H-2,10b-diaza- aceanthrylen-5-ylamino)propyl]piperazin-1-yl}-propyl)-2-aza-phenalene-1,3-dione, has been shown to be a potent cell growth inhibitor. To investigate HKH40A actions, we focused on exploring the signal transduction pathways that are involved in its cell growth inhibitory mechanisms. We found that HKH40A activated ataxia telangiectasia mutated (ATM) kinase, which then triggered activation of the Chk1/2 signaling pathway, evidenced by Chk1/2 mediated inhibitory phosphorylation of Cdc25C protein phosphatase. This resulted in Cdk1 tyrosine phosphorylation at Tyr-15, leading to cell cycle block at G2/M phase. HKH40A also activated the c-Jun N-terminal kinase (JNK) pathway, most likely regulated by ATM kinase, since pre-treatment of Hep3B cells with ATM inhibitor KU-55933 or ATM siRNA transfection antagonized HKH40A-induced c-Jun phosphorylation. HKH40A-induced apoptosis was probably mediated by JNK-H2A.X interaction, since phospho-c-Jun and phospho-H2A.X were able to co-localize in the nucleus and to co-immuno-precipitate. Furthermore, inhibition of JNK kinase activity by JNK inhibitor SP600125 abolished both HKH40A-induced H2A.X phosphorylation and apoptosis. Our data support the hypothesis that binding of HKH40Ato cellular DNA likely activates ATM kinase, which then induces parallel Chk 1/2 and JNK signaling pathways, leading to G2/M cell cycle block and apoptosis.

AB - HKH40A (RTA 502), or 5-nitro-2-(3-{4-[3-(8-methoxy-6-oxo-6H-2,10b-diaza- aceanthrylen-5-ylamino)propyl]piperazin-1-yl}-propyl)-2-aza-phenalene-1,3-dione, has been shown to be a potent cell growth inhibitor. To investigate HKH40A actions, we focused on exploring the signal transduction pathways that are involved in its cell growth inhibitory mechanisms. We found that HKH40A activated ataxia telangiectasia mutated (ATM) kinase, which then triggered activation of the Chk1/2 signaling pathway, evidenced by Chk1/2 mediated inhibitory phosphorylation of Cdc25C protein phosphatase. This resulted in Cdk1 tyrosine phosphorylation at Tyr-15, leading to cell cycle block at G2/M phase. HKH40A also activated the c-Jun N-terminal kinase (JNK) pathway, most likely regulated by ATM kinase, since pre-treatment of Hep3B cells with ATM inhibitor KU-55933 or ATM siRNA transfection antagonized HKH40A-induced c-Jun phosphorylation. HKH40A-induced apoptosis was probably mediated by JNK-H2A.X interaction, since phospho-c-Jun and phospho-H2A.X were able to co-localize in the nucleus and to co-immuno-precipitate. Furthermore, inhibition of JNK kinase activity by JNK inhibitor SP600125 abolished both HKH40A-induced H2A.X phosphorylation and apoptosis. Our data support the hypothesis that binding of HKH40Ato cellular DNA likely activates ATM kinase, which then induces parallel Chk 1/2 and JNK signaling pathways, leading to G2/M cell cycle block and apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=69249228676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249228676&partnerID=8YFLogxK

U2 - 10.1002/jcp.21844

DO - 10.1002/jcp.21844

M3 - Article

C2 - 19530246

AN - SCOPUS:69249228676

VL - 221

SP - 213

EP - 220

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 1

ER -